SK Hynix’s rise to South Korea’s most valuable listed company reflects a long-term bet on HBM chips that became central to the AI boom. Bac...

India and the US are pushing for an interim trade pact, with high-level talks led by Piyush Goyal and Jamieson Greer aiming for a deal befo...

General Motors Detroit plant robots: General Motors has introduced 50 collaborative robots at its Factory Zero plant, a move that has led t...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Steel giant ArcelorMittal is joining forces with Amazon Web Services (AWS) to revolutionize its global operations. By integrating AWS's clo...

GRSE shares surged nearly 5% after the defence PSU was granted Navratna status, boosting investor sentiment. The status allows greater fina...

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...

Defence PSU Garden Reach Shipbuilders and Engineers (GRSE) Ltd has achieved 'Navratna' status, a significant recognition of its consistent ...

In an interaction with Kshitij Anand of ETMarkets, Bharaddia explains why his firm continues to follow a private equity-style investing app...

Indian businesses, particularly MSMEs, are hesitant to adopt yuan-denominated settlements despite a weakening rupee. They prioritise locali...

The global copper market is on edge as President Trump weighs imposing tariffs on refined copper imports. A decision, expected soon, could ...

Prime Minister Narendra Modi met top business leaders in Paris. Discussions focused on investment and expansion in India. Companies from su...

America is investing heavily in its chip industry. The US government has given a massive $500 million to SandboxAQ. This company will devel...

India's defence production has surged to a record Rs 1.78 lakh crore in FY26, nearly quadrupling since 2013-14. This growth, fueled by the ...

Abakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...

India is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...